Results 251 to 260 of about 8,093,285 (389)

Tumor‐agnostic detection of circulating tumor DNA in patients with advanced pancreatic cancer using targeted DNA methylation sequencing and cell‐free DNA fragmentomics

Molecular Oncology, EarlyView.
We evaluated circulating tumor DNA (ctDNA) detection in advanced pancreatic cancer using DNA methylation, cell‐free DNA fragment lengths, and 5′ end motifs. Machine learning models were trained to estimate ctDNA levels from each feature and their combination.
Morten Lapin, Kjersti Tjensvoll, Karin Hestnes Edland, Satu Oltedal, Herish Garresori, Bjørnar Gilje, Saga Ekedal, Trygve Eftestøl, Jan Terje Kvaløy, Filip Janku, Oddmund Nordgård   +10 more
wiley   +1 more source

Patient reported outcomes in pediatric physical therapy: a scoping review and evidence map. [PDF]

J Patient Rep Outcomes
Korteling DL, Limmen S, Ketelaar M, Daams JG, Luijten MAJ, van Oers HA, Bloemen MAT, Haverman L, Engelbert RHH.   +8 more
europepmc   +1 more source

PCN32 INSTRUMENTS TO MEASURE PATIENT-REPORTED OUTCOMES AND PERCEPTIONS OF CANCER-RELATED FATIGUE: A REVIEW OF THE LITERATURE

, 2004
Eva Baró, MJ Herdman, JA Gasquet, Judit Sánchez   +3 more
openalex   +1 more source

Impact of efalizumab on patient-reported outcomes in high-need psoriasis patients: results of the international, randomized, placebo-controlled Phase III Clinical Experience Acquired with Raptiva (CLEAR) trial [NCT00256139] [PDF]

, 2005
Jean‐Paul Ortonne, Neil H. Shear, Stephen Shumack, Eric Henninger   +3 more
openalex   +1 more source

Gut microbiota diversity is prognostic in metastatic hormone receptor‐positive breast cancer patients receiving chemotherapy and immunotherapy

Molecular Oncology, EarlyView.
In this exploratory study, we investigated the relationship between the gut microbiota and outcome in patients with metastatic hormone receptor‐positive breast cancer, treated in a randomized clinical trial with chemotherapy alone or chemotherapy in combination with immune checkpoint blockade.
Andreas Ullern, Kristian Holm, Nikolai Kragøe Andresen, Andreas Hagen Røssevold, Corinna Bang, Bjørn Naume, Johannes R. Hov, Jon Amund Kyte   +7 more
wiley   +1 more source

Redefining Success in Hernia Surgery: The Case for Patient-Reported Outcomes. [PDF]

J Clin Med
Rosenberg J, Gram-Hanssen A, Reistrup H, Baker JJ.   +3 more
europepmc   +1 more source

PGI11 PSYCHOMETRIC VALIDATION OF TWO GASTROINTESTINAL (GI)-SPECIFIC PATIENT-REPORTED OUTCOME (PRO) INSTRUMENTS IN RENAL TRANSPLANT PATIENTS WITH AND WITHOUT GI COMPLICATIONS

, 2004
Leah Kleinman, Udo Bahner, Richard L. M. Faull, R Walker, Ram Prasad, Patrice Max Ambuehl, Gerardo Machnicki, MK Margolis   +7 more
openalex   +1 more source

Symptom Monitoring in Pediatric Oncology Using Patient-Reported Outcomes: Why, How, and Where Next

Patient, 2018
A. Leahy, C. Feudtner, E. Basch
semanticscholar   +1 more source

A bioinformatics screen identifies TCF19 as an aggressiveness‐sustaining gene in prostate cancer

Molecular Oncology, EarlyView.
Gene expression meta‐analysis in multiple prostate cancer patient cohorts identifies Transcription factor 19 (TCF19) as an aggressiveness‐sustaining gene with prognostic potential. TCF19 is a gene repressed by androgen signaling that sustains core cancer‐related processes such as vascular permeability or tumor growth and metastasis.
Amaia Ercilla, Jana R. Crespo, Saioa Garcia‐Longarte, Marta Fidalgo, Sara del Palacio, Natalia Martin‐Martin, Onintza Carlevaris, Ianire Astobiza, Sonia Fernández‐Ruiz, Marc Guiu, Laura Bárcena, Isabel Mendizabal, Ana M. Aransay, Mariona Graupera, Roger R. Gomis, Arkaitz Carracedo   +15 more
wiley   +1 more source

Patient-reported outcomes after chemoradiotherapy for anal cancer. [PDF]

Acta Oncol
Slørdahl KS, Skovlund E, Olsen JÅ, Tvedt R, Thomsen M, Kaasa S, Guren MG.   +6 more
europepmc   +1 more source